Table 2.
Univariate survival analysis for patients with UUS
| Clinical Characteristics | n | % | mPFS (months) | P value | mOS (months) | P value |
|---|---|---|---|---|---|---|
| Age (years) | 0.508 | 0.448 | ||||
| <50 | 10 | 34.5 | 14.43 | 52.9 | ||
| ≥50 | 19 | 65.5 | 17.73 | 27.4 | ||
| BMI (kg/m2) | 0.844 | 0.349 | ||||
| <24 | 15 | 51.7 | 12.8 | 22.2 | ||
| ≥24 | 14 | 48.3 | 15.53 | 28.2 | ||
| Tumor size (cm) | 0.121 | 0.324 | ||||
| <10 | 15 | 51.7 | 25.87 | 35.03 | ||
| ≥10 | 14 | 48.3 | 6.47 | 20.43 | ||
| FIGO Stage | 0.003 | 0.087 | ||||
| I-II | 22 | 75.9 | 17.73 | 35.03 | ||
| III-IV | 7 | 24.1 | 5.97 | 6.67 | ||
| Lymphadenectomy | 0.010 | 0.201 | ||||
| Yes | 17 | 58.6 | 25.23 | 52.9 | ||
| No | 12 | 41.4 | 9.7 | 20.4 | ||
| Omentectomy | 0.016 | 0.078 | ||||
| Yes | 8 | 27.6 | NR | 99.9 | ||
| No | 21 | 72.4 | 11.97 | 21.8 | ||
| Myometrial invasion | 0.090 | 0.671 | ||||
| <1/2 | 11 | 37.9 | 25.87 | 35 | ||
| ≥1/2 | 16 | 55.2 | 11.4 | 20.4 | ||
| NA | 2 | 6.9 | ||||
| Cervical involvement | 0.588 | 0.353 | ||||
| Yes | 4 | 13.8 | 6.467 | 6.47 | ||
| No | 23 | 79.3 | 17.07 | 35 | ||
| NA | 2 | 6.9 | ||||
| Adjuvant chemotherapy | 0.220 | 0.062 | ||||
| Yes | 23 | 79.3 | 17.73 | 35.03 | ||
| No | 6 | 20.7 | 14.43 | 14.43 | ||
Abbreviation: UUS, undifferentiated uterine sarcomas; mPFS, median progression free survival; mOS, median overall survival; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; NA, not available